Militia Capital Management LLC Makes New Investment in iShares Biotechnology ETF $IBB

Militia Capital Management LLC bought a new stake in shares of iShares Biotechnology ETF (NASDAQ:IBB) in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 24,100 shares of the financial services provider’s stock, valued at approximately $4,069,000. iShares Biotechnology ETF accounts for about 0.9% of Militia Capital Management LLC’s investment portfolio, making the stock its 19th biggest holding. Militia Capital Management LLC owned approximately 0.05% of iShares Biotechnology ETF at the end of the most recent quarter.

Several other institutional investors and hedge funds have also bought and sold shares of IBB. Allspring Global Investments Holdings LLC increased its holdings in iShares Biotechnology ETF by 46,806.0% during the fourth quarter. Allspring Global Investments Holdings LLC now owns 46,906 shares of the financial services provider’s stock worth $7,927,000 after buying an additional 46,806 shares during the last quarter. Tudor Investment Corp ET AL bought a new position in shares of iShares Biotechnology ETF in the third quarter valued at approximately $931,000. McElhenny Sheffield Capital Management LLC purchased a new position in shares of iShares Biotechnology ETF during the 4th quarter valued at $25,400,000. WorthPointe LLC purchased a new position in shares of iShares Biotechnology ETF during the fourth quarter worth about $1,424,000. Finally, Assetmark Inc. raised its position in shares of iShares Biotechnology ETF by 150,979.6% during the 4th quarter. Assetmark Inc. now owns 74,029 shares of the financial services provider’s stock valued at $12,494,000 after buying an additional 73,980 shares in the last quarter. 62.45% of the stock is owned by institutional investors.

iShares Biotechnology ETF Stock Down 1.2%

Shares of IBB opened at $187.00 on Thursday. iShares Biotechnology ETF has a 1 year low of $130.25 and a 1 year high of $199.05. The stock has a 50 day simple moving average of $178.75 and a two-hundred day simple moving average of $173.81.

iShares Biotechnology ETF Cuts Dividend

The business also recently announced a quarterly dividend, which was paid on Thursday, June 18th. Investors of record on Monday, June 15th were issued a dividend of $0.0238 per share. The ex-dividend date was Monday, June 15th. This represents a $0.10 annualized dividend and a yield of 0.1%.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.